financial analysis Essays

Submitted By QURQAR
Words: 1509
Pages: 7

INVESTOR PRESENTATION
January 10, 2011

FORWARD‐LOOKING STATEMENTS
FORWARD‐LOOKING STATEMENTS
Certain statements in this presentation may constitute “forward‐looking”
statements that involve known and unknown risks, uncertainties and
other factors that may cause the actual results, performance or
achievements of the Company, or industry results, to be materially
different from any future results, performance or achievements
expressed or implied by such forward‐looking statements. The Company
disclaims any intention or obligation to update or revise any forward
forward‐
looking statements, whether as a result of new information, future
events or otherwise, other than as required by law.

2

ATRIUM OVERVIEW
ATRIUM OVERVIEW




Strong commitment to product development and improvements
Strong commitment to product development and improvements –
Innovation Science Committee with over 15 PhDs, MDs, nutritionists
& dieticians



Multi‐channel sales/distribution strategy:
Multi channel sales/distribution strategy:
– Healthcare practitioners
– Health food and specialized stores
– Direct‐to‐consumer
Direct to consumer



Seven GMP compliant manufacturing facilities



3

Extensive portfolio of best‐in‐class, science‐based and professionally
endorsed dietary supplements primarily sold in North America and
Europe

g
p
$
Strategic and disciplined consolidator in $US80 billion+ worldwide
industry

Atrium s Mission
Atrium’s Mission
Grow. In Health.
G
I H lth



Atrium owns and develops unique individual business units that are
dedicated to the promotion of health and well‐being



4

Atrium is committed to supporting optimal health through innovative
science‐based products and services
science based products and services

Atrium is proud to operate a vibrant family of premium brands

EXTENSIVE PRODUCT PORTFOLIO
EXTENSIVE PRODUCT PORTFOLIO

5

GEOGRAPHIC SALES MIX ‐ YEAR‐TO‐DATE
SALES MIX ‐

*

6

* Assuming an exchange rate of 1.35 euro/USD

FINANCIAL PERFORMANCE – 5 YEARS
FINANCIAL PERFORMANCE – 5 YEARS
2009

2005

CAGR

319.7
319 7

32.9
32 9

76.6%
76 6%

EBITDA

80.8

10.5

66.6%

Net Earnings

48.7

5.8

70.2%

$1.47

$0.20

64.7%

53.9

9.5

54.3%

(US$ Millions)

Revenues

EPS
Cash Flow before WC
7

CONVERGENCE – ATRIUM IS WELL POSTIONED
CONVERGENCE – ATRIUM IS WELL POSTIONED

Systemic movement
from “disease care”
to “preventive care”
preventive care
systems worldwide

8

Medicine

Nutrition

COMPLEMENTARY TO HEALTH & NUTRITION
COMPLEMENTARY TO HEALTH & NUTRITION

Preventive Health for
Current Pandemics
Diabetes

Reduced
Stress

Exercise
Dietary
Supplements

Diet

9

Obesity
Heart
ea t
Disease

Cancer

Consumers

• Growth in aging population
• T d t
Trends toward h lth li i
d healthy living
• Self-care a d se educat o
Se ca e and self-education
• Alternative and/or complement to
drugs
• Soaring cost of drugs and
healthcare
10

Medical Establishment Endorsement

• Growing support of medical community
• Part of the education of MDs
• More scientific evidence supporting
industry
• 80% of doctors/nurses use supplements

11

Governments

• H lh
Healthcare reforms worldwide
f
ld id
• Soaring cost of healthcare system and
g
y
the role of preventive medicine
• Increased regulation worldwide

12

DIETARY SUPPLEMENT SALES – BY CHANNEL
DIETARY SUPPLEMENT SALES – BY CHANNEL
2009 U.S.
Supplement
Sales
$7.8

2004-2009

2008-2009

5.1%

10.1%

MLM

$4.5

2.9%

(3.1%)

Mail Order / TV / Radio

$1.5

3.5%

7.2%

Internet

$1.2

23.9%

32.6%

$7.1

5.2%

3.6%

Health Food and Specialized Stores
p

$9 9
$9.9

6 3%
6.3%

6 0%
6.0%

Healthcare Practitioners

$2.1

7.7%

8.2%

$26.9

5.7%

6.7%

(US$ Billions)
Mass Market

CAGR…